Bristol Myers Squibb to Present at J.P. Morgan Investor Conference

Bristol Myers Squibb Sets January 12 for Investor Presentation

Bristol Myers Squibb (NYSE: BMY) announced on January 2, 2026, that it will present at the J.P. Morgan’s 44th Annual Healthcare Conference. The company’s presentation, which includes a fireside chat, is scheduled to begin at 7:30 a.m. UTC-8 (10:30 a.m. ET) on Monday, January 12, 2026. This event is a key fixture in the pharmaceutical industry calendar, drawing significant attention from the investment community.

For interested parties, the presentation will be webcast live on the Bristol Myers Squibb investor relations website. The company confirmed that materials related to the presentation will be posted online at the start of the webcast, and a replay will be archived for future reference.

Investors Await Strategic and Pipeline Updates

The J.P. Morgan Healthcare Conference serves as a critical platform for companies to communicate their strategy, financial outlook, and progress in their drug development pipelines. While the announcement of participation is a routine disclosure, the content of the presentation itself can materially affect investor sentiment.

Investors will be scrutinizing the discussion for any new information regarding the company's key therapeutic areas, updates on clinical trials, and management's outlook for the fiscal year. Any forward-looking statements or new data released during the January 12 event will be pivotal in shaping the market's perception of BMY's valuation and growth prospects.